SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027924
Filing Date
2024-03-07
Accepted
2024-03-07 16:05:38
Documents
91
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K igms-20231231.htm   iXBRL 10-K 3105543
2 EX-10.4 igms-ex10_4.htm EX-10.4 129616
3 EX-10.12 igms-ex10_12.htm EX-10.12 58847
4 EX-21.1 igms-ex21_1.htm EX-21.1 4404
5 EX-23.1 igms-ex23_1.htm EX-23.1 3364
6 EX-31.1 igms-ex31_1.htm EX-31.1 16442
7 EX-31.2 igms-ex31_2.htm EX-31.2 17170
8 EX-32.1 igms-ex32_1.htm EX-32.1 8509
9 EX-32.2 igms-ex32_2.htm EX-32.2 8312
10 EX-97.1 igms-ex97_1.htm EX-97.1 36732
11 GRAPHIC img200968743_0.jpg GRAPHIC 21594
12 GRAPHIC img200968743_1.jpg GRAPHIC 241361
  Complete submission text file 0000950170-24-027924.txt   12086836

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20231231.xsd EX-101.SCH 1561535
93 EXTRACTED XBRL INSTANCE DOCUMENT igms-20231231_htm.xml XML 1899049
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39045 | Film No.: 24730045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)